Search Results - De Roos, J.A.D.M.

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Mechanistic differentiation of PI3K/mTOR, Aurora kinase and EZH2 inhibitor classes by comparative cancer cell line profiling

    Mechanistic differentiation of PI3K/mTOR, Aurora kinase and EZH2 inhibitor classes by comparative cancer cell line profiling by Uitdehaag, J.C.M, De Roos, J.A.D.M, Prinsen, M.B.W, De Vetter, J.R.F, Dylus, J, Van Doornmalen, A.M, Van Gerwen, S.J.C, De Man, J, Buijsman, R.C, Zaman, G.J.R

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Cell panel profiling of pre-clinical and clinical anti-cancer agents reveals conserved therapeutic clusters and differentiates the mechanism of action of different PI3K/mTOR, Aurora kinase and EZH2 inhibitors

    Cell panel profiling of pre-clinical and clinical anti-cancer agents reveals conserved therapeutic clusters and differentiates the mechanism of action of different PI3K/mTOR, Auror... by Uitdehaag, J.C.M, De Roos, J.A.D.M, Prinsen, M.B.W, Willemsen-Seegers, N, De Vetter, J.R.F, Dylus, J, Van Doornmalen, A.M, Kooijman, J, Sawa, M, Van Gerwen, S.J.C, De Man, J, Buijsman, R.C, Zaman, G.J.R

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    349 Synergistic drug combinations that target beta-catenin-driven and MYC-driven cancers

    349 Synergistic drug combinations that target beta-catenin-driven and MYC-driven cancers by Uitdehaag, J.C.M, Spijkers-Hagelstein, J.A.P, de Roos, J.A.D.M, van Doornmalen, A.M, Prinsen, M.B.W, de Man, J, Buijsman, R.C, Zaman, G.J.R

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    655: Identification of new synergistic drug combinations on basis of cell panel profiling

    655: Identification of new synergistic drug combinations on basis of cell panel profiling by Uitdehaag, J.C.M, De Roos, J.A.D.M, Spijkers-Hagelstein, J.A.P, Van Doornmalen, A.M, Prinsen, M.B.W, De Man, J, Buijsman, R.C, Zaman, G.J.R

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    580 - Mechanistic differentiation of PI3K/mTOR, Aurora kinase and EZH2 inhibitor classes by comparative cancer cell line profiling

    580 - Mechanistic differentiation of PI3K/mTOR, Aurora kinase and EZH2 inhibitor classes by comparative cancer cell line profiling by Uitdehaag, J.C.M., De Roos, J.A.D.M., Prinsen, M.B.W., De Vetter, J.R.F., Dylus, J., Van Doornmalen, A.M., Van Gerwen, S.J.C., De Man, J., Buijsman, R.C., Zaman, G.J.R.

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    52 - Cell panel profiling of pre-clinical and clinical anti-cancer agents reveals conserved therapeutic clusters and differentiates the mechanism of action of different PI3K/mTOR, Aurora kinase and EZH2 inhibitors

    52 - Cell panel profiling of pre-clinical and clinical anti-cancer agents reveals conserved therapeutic clusters and differentiates the mechanism of action of different PI3K/mTOR,... by Uitdehaag, J.C.M., De Roos, J.A.D.M., Prinsen, M.B.W., Willemsen-Seegers, N., De Vetter, J.R.F., Dylus, J., Van Doornmalen, A.M., Kooijman, J., Sawa, M., Van Gerwen, S.J.C., De Man, J., Buijsman, R.C., Zaman, G.J.R.

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    PO-484 Development of a two-step screening-and-confirmation approach to efficiently identify synergistic drug combinations with the PARP inhibitor niraparib

    PO-484 Development of a two-step screening-and-confirmation approach to efficiently identify synergistic drug combinations with the PARP inhibitor niraparib by Prinsen, MBW, Vetter, JRF De, Dylus, J, Roos, JADMDe, Gerwen, SJC Van, Buijsman, RC, UItdehaag, JCM

    Published in ESMO open
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    PO-456 Cell line panel profiling of all clinically approved kinase inhibitors for cancer treatment

    PO-456 Cell line panel profiling of all clinically approved kinase inhibitors for cancer treatment by Kooijman, JJ, Uitdehaag, JCM, Roos, JADMDe, Vetter, JRF De, Prinsen, MBW, Dylus, J, Man, J De, Gerwen, SJC Van, Buijsman, RC, Zaman, GJR

    Published in ESMO open
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: